Substances for preventing and treating autoimmune diseases
AssigneeLoma Linda University
InventorsAlan Escher, Fengchun Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeLoma Linda University
InventorsAlan Escher, Fengchun Li
Estimating the term…
A substance for preventing, delaying the onset of, or treating one or more than one autoimmune disease, the substance comprising a polynucleotide construct comprising a polynucleotide sequence encoding the pro-apoptotic protein BAX and encoding one or more than one autoantigen for the autoimmune disease. A method for preventing, delaying the onset of or treating an autoimmune disease in a patient comprising selecting a patient who is susceptible to developing the autoimmune disease, who is developing the autoimmune disease or who has the autoimmune disease and administering to the patient one or more than one dose of a polynucleotide construct comprising a polynucleotide sequence encoding the pro-apoptotic protein BAX and encoding one or more than one autoantigen for an autoimmune disease, or comprising a polynucleotide sequence encoding the adenoviral protein E3-GP19k, or comprising a polynucleotide sequence encoding ΔBCL-2.
A substance for preventing, delaying the onset of or treating one or more than one autoimmune disease, the substance comprising a polynucleotide construct comprising a polynucleotide sequence encoding the pro-apoptotic protein BAX and encoding one or more than one autoantigen for the autoimmune disease.
Use of a polynucleotide construct comprising a polynucleotide sequence encoding the pro-apoptotic protein BAX and encoding one or more than one autoantigen for an autoimmune disease for the manufacture of a medicament for preventing, delaying the onset of or treating the one or more than one autoimmune disease.
Use of a plasmid comprising a promoter and a polynucleotide sequence encoding only one adenoviral protein, where the only adenoviral protein encoded by the plasmid is E3-GP19k for the manufacture of a medicament for preventing, delaying the onset of or treating one or more than one autoimmune disease.
Use of a plasmid comprising a promoter and a polynucleotide sequence encoding ΔBCL-2 for the manufacture of a medicament for preventing, delaying the onset of or treating one or more than one autoimmune disease.
A method for preventing, delaying the onset of or treating an autoimmune disease in a patient comprising:
A method for preventing, delaying the onset of or treating an autoimmune disease in a patient comprising:
A method for preventing, delaying the onset of or treating an autoimmune disease in a patient comprising:
A method for preventing, delaying the onset of or treating an autoimmune disease in a patient comprising:
Dependencies are inferred from the claim text.